Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

NCT00044395 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies
Diabetes Mellitus, Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG: Ruboxistaurin mesylate

Sponsor

Eli Lilly and Company